Evaluating the long-term effects of Splentis for treating pelvic organ prolapse
Official title: Prospective, Multicenter, 60 Months, Single-arm Cohort Trial for Evaluation of the Efficacy and Safety of Transvaginal Sacrospinous Ligament Fixation With Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
Run by Promedon · NCT05042453 · Data updated 2026-11-12
This study is testing how well the Splentis system works for treating uterine prolapse in women over five years, looking at both how they feel and any side effects they might have.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 140 (estimated) |
| Sponsor | Promedon Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 7 sites (Chemnitz and 6 other locations) |
| Status | Recruiting |
| Started | December 19, 2022 |
| Main results expected | July 2026 |
| Study ends | July 2030 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT05042453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non-fertile women with primary symptomatic uterine descent and a POP-Q score of 2 or higher scheduled for apical repair.
✕Probably not a fit
Patients with recurrent apical prolapse or those with active infections or a history of pelvic cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort trial aims to assess the long-term efficacy and safety of hysteropexy using the Splentis system for women with primary uterine prolapse. Participants will undergo the procedure via the vaginal route and will be followed for 60 months to evaluate various outcomes, including anatomical success, subjective satisfaction, and the need for re-treatment. Secondary endpoints will focus on functional outcomes such as urinary incontinence, overactive bladder symptoms, quality of life, and sexual health, along with a comprehensive report on any adverse events experienced during the study.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for women suffering from primary pelvic organ prolapse.
How similar studies have gone: While this approach is being evaluated in this trial, similar studies have shown promising results with other surgical techniques for pelvic organ prolapse.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * non-fertile women * primary symptomatic uterine descent POP-Q≥2 * Scheduled apical POP repair with Splentis * Willing and able to participate at study visits and to sign informed consent Exclusion Criteria: * Fertile women * Recurrent apical prolapse * Women with post hysterectomy vaginal vault prolapse * Patients with active or latent infection of the vagina, cervix or uterus * Patients with previous or current vaginal, cervical or uterine cancer * Previous, current or planned pelvic radiation therapy * Known allergy to polypropylene.
Where it's running
-
DRK Hospital Chemnitz-Rabenstein
Chemnitz, Germany Recruiting -
Helios Hospital Erfurt, Department of gynaecology
Erfurt, Germany Recruiting -
University Hospital Freiburg
Freiburg im Breisgau, Germany Recruiting -
Clinic Kassel
Kassel, Germany Recruiting -
St. Elisabeth Hospital
Leipzig, Germany Recruiting -
Hospital Tettnang
Tettnang, Germany Recruiting
Show 1 more location
-
University Hospital
Mannheim, Germany Not yet recruiting
Study contacts
- Principal investigator: Gert Naumann, MD — Helios Clinic Erfurt, Germany
- Study coordinator: Philipp Schelhorn
- Email: trials.de@promedon.com
- Phone: 00498031900400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Uroflowmetry: Do Pre-Procedure Reminders Help Women Undergoing Urodynamics
This study tests whether sending reminder calls before a urodynamics test helps women with pelvic floor disorders feel more prepared and less anxious, and whether it makes the procedure go more smoothly.
-
Vaginal Vault Support at Hysterectomy
This trial tests a new double-ligament vault suspension during hysterectomy to help prevent vaginal apex prolapse in women undergoing the procedure.
-
Centered Surgery: Preoperative Counseling to Improve Patient Satisfaction
This study will test whether virtual group counseling sessions (shared medical appointments) help adults having pelvic organ prolapse surgery feel more satisfied and better prepared compared with standard individual phone calls.
-
Pelvic floor muscle training with and without hypopressive exercises for women with pelvic organ prolapse
This will test whether adding hypopressive exercises to pelvic floor muscle training helps women aged 45–65 with stage I–II pelvic organ prolapse improve pelvic floor strength, reduce pain during sex, and feel better overall.
-
Wrist activity tracking to guide early recovery after pelvic organ prolapse surgery
This study will try giving women having pelvic organ prolapse surgery either usual postoperative advice or a guided early-exercise plan while tracking activity with a wrist accelerometer to see which group reaches "mostly recovered" sooner.
-
Mesh-free sacrocolpopexy using the VNOTES (transvaginal endoscopic) approach for pelvic organ prolapse
This trial will try mesh-free sacrocolpopexy using the VNOTES transvaginal endoscopic technique in women with stage II or higher pelvic organ prolapse to see if it improves pelvic support, symptoms, and sexual function over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.